The use of missing values in proteomic data-independent acquisition mass spectrometry to enable disease activity discrimination.


Journal

Bioinformatics (Oxford, England)
ISSN: 1367-4811
Titre abrégé: Bioinformatics
Pays: England
ID NLM: 9808944

Informations de publication

Date de publication:
01 04 2020
Historique:
received: 16 09 2019
revised: 14 11 2019
accepted: 26 11 2019
pubmed: 4 12 2019
medline: 17 9 2020
entrez: 3 12 2019
Statut: ppublish

Résumé

Data-independent acquisition mass spectrometry allows for comprehensive peptide detection and relative quantification than standard data-dependent approaches. While less prone to missing values, these still exist. Current approaches for handling the so-called missingness have challenges. We hypothesized that non-random missingness is a useful biological measure and demonstrate the importance of analysing missingness for proteomic discovery within a longitudinal study of disease activity. The magnitude of missingness did not correlate with mean peptide concentration. The magnitude of missingness for each protein strongly correlated between collection time points (baseline, 3 months, 6 months; R = 0.95-0.97, confidence interval = 0.94-0.97) indicating little time-dependent effect. This allowed for the identification of proteins with outlier levels of missingness that differentiate between the patient groups characterized by different patterns of disease activity. The association of these proteins with disease activity was confirmed by machine learning techniques. Our novel approach complements analyses on complete observations and other missing value strategies in biomarker prediction of disease activity. Supplementary data are available at Bioinformatics online.

Identifiants

pubmed: 31790148
pii: 5650405
doi: 10.1093/bioinformatics/btz898
pmc: PMC7141869
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2217-2223

Subventions

Organisme : Medical Research Council
ID : MR/M008959/1
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/15/12/31616
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CH/13/2/30154
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N00583X/1
Pays : United Kingdom
Organisme : Blood Cancer UK
ID : 13005
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C5759/A25254
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K501311/1
Pays : United Kingdom

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press.

Références

Nat Biotechnol. 2014 Mar;32(3):219-23
pubmed: 24727770
Nat Methods. 2016 Sep;13(9):777-83
pubmed: 27479329
J Proteomics. 2018 Oct 30;189:11-22
pubmed: 29501709
Front Pharmacol. 2018 Jun 26;9:681
pubmed: 29997509
Bioinformatics. 2003 Nov 1;19(16):2088-96
pubmed: 14594714
Mol Cell Proteomics. 2012 Jun;11(6):O111.016717
pubmed: 22261725
Sci Rep. 2018 Jan 12;8(1):663
pubmed: 29330539
BMC Bioinformatics. 2012;13 Suppl 16:S5
pubmed: 23176322
JMIR Med Inform. 2018 Feb 23;6(1):e11
pubmed: 29475824
Nat Biotechnol. 2016 Nov;34(11):1130-1136
pubmed: 27701404
Metabolites. 2014 Jun 16;4(2):433-52
pubmed: 24957035
Arthritis Rheum. 1995 Jan;38(1):44-8
pubmed: 7818570
J Proteome Res. 2016 Apr 1;15(4):1116-25
pubmed: 26906401
PLoS One. 2017 Dec 20;12(12):e0189875
pubmed: 29261781
Am J Epidemiol. 2017 Feb 15;185(4):304-315
pubmed: 28073767
Bioinformatics. 2015 Feb 15;31(4):555-62
pubmed: 25348213
Proteomics. 2015 Sep;15(18):3163-8
pubmed: 25656970
Bioinformatics. 2014 Sep 1;30(17):2524-6
pubmed: 24794931
Science. 2018 Feb 23;359(6378):926-930
pubmed: 29348365
Eur J Epidemiol. 2019 Jan;34(1):23-36
pubmed: 30341708
BMC Womens Health. 2019 Feb 26;19(1):38
pubmed: 30808349
Front Mol Biosci. 2015 Feb 02;2:4
pubmed: 25988172
J Proteome Res. 2015 May 1;14(5):1993-2001
pubmed: 25855118
Sci Rep. 2018 Apr 17;8(1):6085
pubmed: 29666385
PLoS Med. 2015 Mar 31;12(3):e1001779
pubmed: 25826379

Auteurs

Kathryn A McGurk (KA)

Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.
Stoller Biomarker Discovery Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Laboratory for Lipidomics and Lipid Biology, Division of Pharmacy and Optometry, UK.

Arianna Dagliati (A)

Division of Informatics, Imaging and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, UK.

Davide Chiasserini (D)

Stoller Biomarker Discovery Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

Dave Lee (D)

Stoller Biomarker Discovery Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

Darren Plant (D)

NIHR Manchester Biomedical Research Centre, Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester, UK.

Ivona Baricevic-Jones (I)

Stoller Biomarker Discovery Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

Janet Kelsall (J)

Stoller Biomarker Discovery Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

Rachael Eineman (R)

Stoller Biomarker Discovery Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

Rachel Reed (R)

Stoller Biomarker Discovery Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

Bethany Geary (B)

Stoller Biomarker Discovery Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

Richard D Unwin (RD)

Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.
Stoller Biomarker Discovery Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

Anna Nicolaou (A)

Laboratory for Lipidomics and Lipid Biology, Division of Pharmacy and Optometry, UK.

Bernard D Keavney (BD)

Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.

Anne Barton (A)

NIHR Manchester Biomedical Research Centre, Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester, UK.
Arthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, University of Manchester, Manchester, UK.

Anthony D Whetton (AD)

Stoller Biomarker Discovery Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

Nophar Geifman (N)

Division of Informatics, Imaging and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH